Daiichi-Sankyo and AstraZeneca offer the Enhertu4U support program to provide information and assistance to patients who have been prescribed Enhertu (Table).
Eligible patients may pay as little as $0 per Enhertu prescription, up to $26,000 per calendar year. To qualify, patients must:
Other restrictions may apply.
The Patient Assistance Programs provide Enhertu at no cost to qualifying uninsured, underinsured, or Medicare patients who are having financial difficulty affording their medication. To be eligible, patients must:
If the patient is a Medicare beneficiary, the patient:
If the patient has experienced a life-changing event in the past year, and financial documentation does not accurately reflect the current situation, the patient may still meet the criteria to enroll and is encouraged to apply.
The Free Limited Supply Program is available for eligible patients who are experiencing a coverage delay of more than 5 business days.
Assistance may also be available through independent foundations. Although not associated with Daiichi-Sankyo or AstraZeneca, names and links to several foundations are available online.
Have you encountered a problem with a URL (link) on this page not loading correctly or is displaying an error message?
Help us fix it! Report broken links here.
Report Broken Links
Submit